Your browser doesn't support javascript.
loading
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
Steensma, David P; Fenaux, Pierre; Van Eygen, Koen; Raza, Azra; Santini, Valeria; Germing, Ulrich; Font, Patricia; Diez-Campelo, Maria; Thepot, Sylvain; Vellenga, Edo; Patnaik, Mrinal M; Jang, Jun Ho; Varsos, Helen; Bussolari, Jacqueline; Rose, Esther; Sherman, Laurie; Sun, Libo; Wan, Ying; Dougherty, Souria; Huang, Fei; Feller, Faye; Rizo, Aleksandra; Platzbecker, Uwe.
Afiliación
  • Steensma DP; Dana-Farber Cancer Institute, Boston, MA.
  • Fenaux P; Hôpital Saint-Louis, Université Paris Diderot, Paris, France.
  • Van Eygen K; Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium.
  • Raza A; Columbia University Medical Center, New York, NY.
  • Santini V; MDS Unit, AOU Careggi-University of Florence, Florence, Italy.
  • Germing U; Klinik für Hämatologie, Onkologie and Klinische lmmunologie, Universitätsklinik Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany.
  • Font P; Department of Hematology, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
  • Diez-Campelo M; Hematology Department, The University Hospital of Salamanca, Salamanca, Spain.
  • Thepot S; CHU Angers, Angers, France.
  • Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Jang JH; Department of Hematology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Varsos H; Janssen Research & Development, Raritan, NJ.
  • Bussolari J; Janssen Research & Development, Raritan, NJ.
  • Rose E; Janssen Research & Development, Raritan, NJ.
  • Sherman L; Geron Corporation, Menlo Park, CA.
  • Sun L; Geron Corporation, Menlo Park, CA.
  • Wan Y; Geron Corporation, Menlo Park, CA.
  • Dougherty S; Geron Corporation, Menlo Park, CA.
  • Huang F; Geron Corporation, Menlo Park, CA.
  • Feller F; Geron Corporation, Menlo Park, CA.
  • Rizo A; Geron Corporation, Menlo Park, CA.
  • Platzbecker U; Department of Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany.
J Clin Oncol ; 39(1): 48-56, 2021 01 01.
Article en En | MEDLINE | ID: mdl-33108243
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos / Síndromes Mielodisplásicos / Inhibidores Enzimáticos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos / Síndromes Mielodisplásicos / Inhibidores Enzimáticos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos